
news

The Russian market receives the first batch of the original innovative drug Areima® (camrelizumab)







The Russian market receives the first batch of the original innovative drug Areima® (camrelizumab)
This site contains information for medical and pharmaceutical professionals.
To view the content, please, confirm that you have the appropriate qualifications.